Daily Digest
India to Launch First Approved Dengue Vaccine Qdenga
Published Friday, September 18, 2026
Narrative Spectrum
- Single-Source Coverage — 1 source
What We Know — Key Points
Key points are extracted by an AI model and may contain errors or omissions. Always check the original sources.- Qdenga is India's first approved dengue vaccine, having received marketing authorisation from the Central Drugs Standard Control Organisation (CDSCO) in July 2026 for individuals aged 4-60 years.
What Is Claimed — Perspectives
Single-Source Coverage
- The Hindu
The article emphasizes the importance of Qdenga's introduction as India's first approved dengue vaccine for the country's healthcare landscape and its potential to address the significant public health challenge posed by dengue.
- Read original →· Sep 18
AI-Generated Content
- This topic was generated by an AI system.
- Key points, perspectives, bias labels, and categorisation may contain errors.
- This is not journalism. Do not rely on this content for critical decisions.
- Read our full AI disclaimer for details.